From Biogen’s AdComm Meeting Will Test FDA’s “Substantial Evidence” Flexibility:

alzheimers-disease-neurons-with-amyloid-plaques-picture-id151645089

alzheimers-disease-neurons-with-amyloid-plaques-picture-id151645089—

Image: iStock/selvanegra
https://www.istockphoto.com/portfolio/selvanegra?assettype=image&mediatype=photography&sort=best

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
CMC in Drug Development and Life Cycle Management
PRA Health Sciences

Xconomy on Demand

We offer a number of ways to subscribe for free!